(Q39330549)

11 September 2017

title

Novel dual inhibitors of vascular endothelial growth factor and VEGFR2 receptor (English)

1 reference

11 September 2017

0 references

Jennifer P Nguyen

1

1 reference

11 September 2017

Chelsea D Frost

2

1 reference

11 September 2017

Meghan L Lane

3

1 reference

11 September 2017

William P Skelton Iv

4

1 reference

11 September 2017

Michelle Skelton

5

1 reference

11 September 2017

David L Vesely

6

1 reference

11 September 2017

publication date

15 June 2012

1 reference

European Journal of Clinical Investigation

11 September 2017

published in

1 reference

11 September 2017

volume

42

1 reference

11 September 2017

issue

10

1 reference

11 September 2017

page(s)

1061-1067

1 reference

Angiogenesis: an organizing principle for drug discovery?

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02695.X

Vascular endothelial growth factor: basic science and clinical progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02695.X

Vascular endothelial growth factor and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02695.X

Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02695.X

Hypoxia enhances FGF2- and VEGF-stimulated human placental artery endothelial cell proliferation: roles of MEK1/2/ERK1/2 and PI3K/AKT1 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02695.X

VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02695.X

VEGF receptor signaling in tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02695.X

Cardiac and kidney hormones cure up to 86% of human small-cell lung cancers in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02695.X

Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02695.X

Modes of resistance to anti-angiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02695.X

FDA. Once on 'fast track,' avastin now derailed

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02695.X

Vessel dilator enhances sodium and water excretion and has beneficial hemodynamic effects in persons with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02695.X

Both v-Ha-Ras and v-Raf Stimulate Expression of the Vascular Endothelial Growth Factor in NIH 3T3 Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02695.X

Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02695.X

Vascular Endothelial Growth Factor Induction of the Angiogenic Phenotype Requires Ras Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02695.X

10.1111/J.1365-2362.2012.02695.X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference